Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in children worldwide and is a significant cause of hospital admissions in young children in England. No RSV vaccine has been licensed but a number are under development. In this work, we present two structurally d...

Full description

Bibliographic Details
Main Authors: Timothy Kinyanjui, Wirichada Pan-Ngum, Sompob Saralamba, Sylvia Taylor, Lisa White, D. James Nokes
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:Vaccine: X
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136220300024